Candidate to Receive

Patients will receive the following study treatments:

• Two active study drugs (5 mg saxagliptin and 5 mg dapagliflozin) OR

• One active study drug (5 mg dapagliflozin) and one placebo (instead of saxagliptin) OR

• One active study drug (5 mg saxagliptin) and one placebo (instead of dapagliflozin) Patients will receive the following during their voluntary study participation:

• Study medication

• Diabetes counseling

• Glucometer and supplies

• Compensation for time and travel expenses